MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-UP-01-0000236
JD Sams Pharmaceuticals Private Limited
JD Sams Pharmaceuticals Private Limited - trading in Agra, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹14.22 Lakh
▼ 19% YoY
Net loss · FY 2025
₹1,823
Net margin -0.1%
EBITDA · FY 2025
₹5,727
EBITDA margin 0.4%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
13 yrs
Est. 2013
Directors on board
3
As per MCA filings
Active GSTINs
1
GST registered
About JD Sams Pharmaceuticals Private Limited
Data last updated:
JD Sams Pharmaceuticals Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 22 July 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2013PTC058505. Its GSTIN is 09AADCJ1395B1ZQ (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Mohit Jain and Anil Kumar Bhadauria.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 4/45 Kacheri Ghant Kuwa Wali Bazaria, Agra, Uttar Pradesh, India – 282004.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.22 Lakh, a decline of 19% compared to the previous year. For the same year it recorded a net loss of ₹1,823 (net margin -0.1%) and EBITDA of ₹5,727 (EBITDA margin 0.4%). Revenue has declined at a compounded annual rate (CAGR) of 10% over three years and 9% over five years.
JD Sams Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-01-0000236). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24233UP2013PTC058505
Registration Number 058505
Incorporation Date 22 July 2013
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-01-0000236
Recognitions & Rankings of JD Sams Pharmaceuticals
Contact details
JD Sams Pharmaceuticals Private Limited's registered office is in Agra, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address4/45 Kacheri Ghant Kuwa Wali Bazaria, Agra, Uttar Pradesh, India – 282004
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of JD Sams Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
JD Sams Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of JD Sams Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of JD Sams Pharmaceuticals Private Limited, buy the company report.
Financials of JD Sams Pharmaceuticals Private Limited
FY 2025 filings availableJD Sams Pharmaceuticals Private Limited reported revenue of ₹14.22 Lakh (down 19% YoY) for FY 2025.
Revenue · FY 2025
₹14.22 Lakh ▼ 19%
Net loss · FY 2025
₹1,823 margin -0.1%
EBITDA · FY 2025
₹5,727 margin 0.4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 10%
5 years · compounded
▼ 9%
EBITDA CAGR growth
1 year
▼ 55%
3 years · compounded
▼ 17%
5 years · compounded
▼ 16%
Revenue has declined at a compounded annual rate (CAGR) of 9% over five years, including a 19% fall in the latest year. EBITDA fell 55% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5,727 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1,823 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.4% | ||||
| Net Profit Margin | -0.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of JD Sams Pharmaceuticals Private Limited, buy the company report.
Board of directors of JD Sams Pharmaceuticals Private Limited
JD Sams Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Jain | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
| Anil Kumar Bhadauria | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
| Sunil Devrani | Director | 22 Jul 2013 | 13 Years 3 Months | Current |
Peer comparison
JD Sams Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Life Science Pharmaceuticals Private Limited | ₹14.26 Lakh (FY 2024) | 199.0% | New Delhi, Delhi, India | |||
| Sensational Pharmaceuticals Private Limited | ₹14.24 Lakh (FY 2021) | 435.0% | Gurgaon, Haryana, India | |||
| Vishrava Pharmaceuticals Private Limited | ₹14.23 Lakh (FY 2022) | 16.0% | Thane, Maharashtra, India | |||
| Cytogen Pharmaceuticals (India) Private Limited | ₹14.23 Lakh (FY 2022) | -16.0% | New Delhi, Delhi, India | |||
| JD Sams Pharmaceuticals Private Limitedthis company | ₹14.22 Lakh (FY 2025) | -₹1,823 | -0.1% | -19.0% | Agra, Uttar Pradesh, India | |
| Efficace Pharmaceuticals Private Limited | ₹14.17 Lakh (FY 2025) | -18.0% | Delhi, India |
To see the full peer comparison of JD Sams Pharmaceuticals Private Limited, buy the company report.
Auditor
JD Sams Pharmaceuticals Private Limited is audited by A.C.H.G & ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A.C.H.G & ASSOCIATES | FY 2017 | 012705C |
Shareholding
The shareholding of JD Sams Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of JD Sams Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving JD Sams Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for JD Sams Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
JD Sams Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AADCJ1395B1ZQ | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of JD Sams Pharmaceuticals Private Limited, buy the company report.
Recent activity
JD Sams Pharmaceuticals Private Limited has 4 board changes on record since 2013: 3 appointments and 1 cessation. The latest: Sudhir Kumar ceased to be Director on 20 May 2017.
AGM
Jd Sams Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jd Sams Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Ceased
Sudhir Kumar ceased to be Director.
Appointed
Anil Kumar Bhadauria was appointed as Director.
Appointed
Mohit Jain was appointed as Director.
Appointed
Sunil Devrani was appointed as Director.
Incorporation
22 Jul 2013
Jd Sams Pharmaceuticals Private Limited was registered on 22 Jul 2013 with Roc Kanpur & aged 13 years 3 months as per MCA records.
Frequently asked questions
JD Sams Pharmaceuticals is an active private limited company based in Agra, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 22 July 2013 (13+ years old) and is registered under CIN U24233UP2013PTC058505.
JD Sams Pharmaceuticals has 3 current directors:
- Mohit Jain - Director
- Anil Kumar Bhadauria - Director
- Sunil Devrani - Director
The latest financial statements of JD Sams Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of JD Sams Pharmaceuticals is 09AADCJ1395B1ZQ, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of JD Sams Pharmaceuticals is U24233UP2013PTC058505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
JD Sams Pharmaceuticals was incorporated on 22 July 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of JD Sams Pharmaceuticals by revenue are Life Science Pharmaceuticals Private Limited, Sensational Pharmaceuticals Private Limited, Vishrava Pharmaceuticals Private Limited, Cytogen Pharmaceuticals (India) Private Limited, Efficace Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Sudhir Kumar ceased to be Director on 20 May 2017. Anil Kumar Bhadauria was appointed as Director on 22 Jul 2013. Mohit Jain was appointed as Director on 22 Jul 2013. JD Sams Pharmaceuticals has 4 board changes on record in total.
Yes, JD Sams Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-01-0000236).
The registered office of JD Sams Pharmaceuticals is at 445 Kacheri Ghant Kuwa Wali Bazaria, Agra, Uttar Pradesh, India – 282004.
JD Sams Pharmaceuticals operates in the trading industry, in the other wholesale segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages